Agilent Technologies 1290 Infinity III Bio LC | Biocompatible UHPLC system
Agilent Technologies 1290 Infinity III Bio LC | Biocompatible UHPLC system — Liquid chromatography.
The 1290 Infinity III Bio LC is a biocompatible UHPLC system configured for biopharmaceutical analysis, with a 300–3,200 m/z mass range and 12 L/min gas flow at 270 °C. It is distinguished within the Bio LC series by its bio-inert flow path and suitability for oligonucleotide and peptide workflows. It serves as the chromatographic front end for LC/MS quantitation and characterization of biologics.
Agilent Technologies Bio LC Solutions Series — Model Comparison & Selection
| Model | Flow rate, liter/minute | Mass range | Max pressure, megapascal | Pumping speed, m³/h | Wavelength range | Sample volume, milliliter |
|---|---|---|---|---|---|---|
| 1290 Infinity III Bio LC | Biocompatible UHPLC system Current | — | 300...3,200 | — | — | — | 0.005 |
| 1260 Infinity Amino Acid Analysis System | — | — | — | — | — | — |
| 1260 Infinity III Bio-Inert LC System | 0.01 | — | 60 | 6×10⁻⁴ | 190...950 | — |
Full specifications
| Gas Flow | 12 L/min |
| Gradient Time | 17 min |
| Sample volume | 5 μL |
| Sheath Gas Flow | 12 L/min |
| LLOQ mfr | 0.2 ng/mL |
| Linear range upper limit mfr | 1000 ng/mL |
| Sensitivity improvement vs organic solvent precipitation mfr | five times times |
| Ion mode mfr | Positive Positive |
| Tirzepatide precursor ion mfr | 1204.4 m/z |
| Tirzepatide product ion mfr | 396.2 m/z |
| Tirzepatide collision energy mfr | 26 |
| Tirzepatide second product ion mfr | 136.1 m/z |
| Tirzepatide second collision energy mfr | 42 |
| Semaglutide precursor ion mfr | 1029.4 m/z |
| Semaglutide product ion mfr | 1238.1 m/z |
| Semaglutide collision energy mfr | 30 |
| Low QC concentration mfr | 0.5 ng/mL |
| Mid QC concentration mfr | 10.00 ng/mL |
| High QC concentration mfr | 800 ng/mL |
| Interday % CV at LLOQ mfr | 6.7 |
| Interday % CV at Low QC mfr | 6.3 |
| Interday % CV at Mid QC mfr | 8.8 |
| Interday % CV at High QC mfr | 5.5 |
| Needle wash mfr | 3 |
| RNase T1 amount mfr | 0.5 units |
| CNP digest amount mfr | 2 μg |
| Solvent A composition mfr | 15 water |
| Sample concentration mfr | 1 mg/mL |
| Heat stress incubation time points mfr | 4 hours |
| Oxidative stress H2O2 concentration mfr | 0.30 |
| Oxidative stress duration mfr | 2 hours |
| Source mfr | Dual AJS AJS |
| Nebulizer mfr | 35 psi |
| Tune Mode mfr | Extended Dynamic Range Range |
| Acquisition Mode mfr | MS Scan Scan |
| MS Scan Range mfr | 400...3,000 |
| Software version mfr | 1.5 |
| Match Tolerance mfr | 10 ppm |
| Mass range | 300...3,200 |
| Skimmer mfr | 65 V |
| Starting material volume mfr | 100 μL |
| Gas Temperature | 270 °C |
| Sample Storage Temperature | 80 °C |
Description
Construction and positioning
- The 1290 Infinity III Bio LC is the biocompatible UHPLC member of the Bio LC Solutions series, positioned above the 1260 Infinity III Bio-Inert LC (600 bar, 10 mL/min, 190–950 nm) and alongside the 1260 Infinity III Prime Bio LC.
- It is intended for biological separations where metal-sensitive analytes and high-pressure operation are both required; the sibling 1260 models cover lower-pressure or prime configurations.
Behavior and workflow context
- Application digests show the system used with a 6495D triple quadrupole for semaglutide/tirzepatide MRM quantitation (LLOQ 0.2 ng/mL, linear to 1,000 ng/mL, interday %CV 5.5–8.8) and with a 6545XT Q-TOF for forced-degradation oligonucleotide mapping.
- Digestion and stress conditions in those methods include 37 °C enzymatic digestion and 80 °C heat stress, indicating the LC must tolerate elevated column temperatures and bio-derived sample matrices.
Installation and operation
- The attached application notes do not provide instrument-level installation, connection, or control details; those must be taken from the separate system manual.
- No certificates or compliance documents are supplied with the verified facts.
Integration & Operating Notes
The system is specified as biocompatible; methods involving oligonucleotides or peptides that adsorb to stainless steel must use the bio-inert configuration throughout, including column hardware, to avoid loss and peak distortion.
The semaglutide quantitation workflow uses MassHunter software to control the LC and MS and to process MRM data; integration planning must include the software license and PC configuration, which are not part of the base instrument delivery.
Selection & Integration Q&A
Choose the 1290 Infinity III Bio LC when the method needs the higher-pressure 1290 platform for small-particle bio columns; the 1260 Infinity III Bio-Inert LC is rated 600 bar and 10 mL/min with 190–950 nm detection, and the Prime Bio LC covers other 1260 configurations. The 1290 is the choice for UHPLC-resolution oligonucleotide and peptide work.
The workflow pairs the bio LC with an Agilent 6495D triple quadrupole LC/MS, an AssayMAP Bravo with RP-S cartridges for sample prep, and MassHunter software for control and data processing. MRM transitions for semaglutide (1029.4 → 1238.1, CE 30) and tirzepatide (1204.4 → 396.2, CE 26) are programmed in the method.
The validated method uses a needle wash of 3 cycles, requiring wash solvent supply and a functioning needle-wash pump; RP-S cartridges for the AssayMAP Bravo and LC columns (e.g., Ultra-Inert hardware for oligonucleotide HILIC) are separate consumables. No service interval is given in the supplied digests; follow the system manual schedule.